Literature DB >> 11439372

Hyaluronan synthases, hyaluronan, and its CD44 receptor in tissue around loosened total hip prostheses.

Y T Konttinen1, T F Li, J Mandelin, M Ainola, J Lassus, I Virtanen, S Santavirta, M Tammi, R Tammi.   

Abstract

Aseptic loosening of prosthetic components, the most common long-term complication after total hip replacement (THR), is characterized by the formation of a synovial membrane-like interface tissue (SMLIT). It was hypothesized that the hyaluronan synthase (HAS)/hyaluronan (HA)/HA receptor CD44 signalling system is responsible for the synovial-like differentiation of the interface membrane. SMLIT was therefore compared with osteoarthritis (OA) synovial membrane by using reverse transcriptase polymerase chain reaction (RT-PCR) of HAS 1, 2 and 3, histochemical HA assay, and immunohistochemistry of CD44 and its non-HA ligands. All three isoforms of HAS were found in these samples. HA and CD44 were most abundant in the lining, but the signal was actually stronger in aseptic loosening than in OA (p<0.01). The non-HA CD44 ligands, collagen type VI, fibronectin, osteopontin, and MCP-1, had a similar distribution pattern in both tissues. These results confirm the synovial-like structure of the interface tissue lining. The pressure waves and movement of the HA-rich pseudosynovial fluid seem to drive HA into the implant-to-host interface, which itself also produces HA. HA may be responsible for the induction of a synovial-like lining at the interface through HA-CD44 signalling. Copyright 2001 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11439372     DOI: 10.1002/1096-9896(200107)194:3<384::AID-PATH896>3.0.CO;2-8

Source DB:  PubMed          Journal:  J Pathol        ISSN: 0022-3417            Impact factor:   7.996


  2 in total

1.  The expression of CD44 in archival paraffin embedded interface tissues of failed orthopaedic implants.

Authors:  Taneisha McFarlane; P A Revell
Journal:  J Mater Sci Mater Med       Date:  2004-04       Impact factor: 3.896

2.  Effects of arecoline on proliferation of oral squamous cell carcinoma cells by dysregulating c-Myc and miR-22, directly targeting oncostatin M.

Authors:  Jureeporn Chuerduangphui; Tipaya Ekalaksananan; Ponlatham Chaiyarit; Natcha Patarapadungkit; Apinya Chotiyano; Bunkerd Kongyingyoes; Supannee Promthet; Chamsai Pientong
Journal:  PLoS One       Date:  2018-01-31       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.